• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Chelsea Property Group

Chelsea Property Group

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor

    Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor

  2. Private Equity Funds for the Masses

    What investors should know before they dive in.

  3. Is Hillshire Worth the Meaty Price?

    A bidding war is sizzling for this meat-centric firm, but Tyson is grazing dangerous terrain.

  4. Our Outlook for Consumer Defensive Stocks

    In the battle between consumer product firms and retailers, has the competitive edge shifted?

  5. Our Outlook for Industrials Stocks

    Most industrials are fairly valued at present, with a pocket of value in automakers.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.